Cui Xiangmin's Form 4 filing
Aardvark Therapeutics, Inc. (AARD) · filed Feb 19, 2025
- Accession no.
- 0000950170-25-023409
- Filed
- Feb 19, 2025, 5:44 PM ET
- Trade date
- Feb 14, 2025
- Filing delay
- 5 days
- Rule 10b5-1 plan
- Not checked
This filing lists 4 non-derivative transactions and 2 derivative transactions. Open-market purchases total $20.0M. It was filed 5 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Cui XiangminCIK 0001487815 | 10% Owner |
| Decheng Capital Global Life Sciences Fund IV, L.P.CIK 0001834150 | 10% Owner |
| Decheng Capital Management IV (Cayman), LLCCIK 0001843384 | 10% Owner |
| Decheng Capital Global Healthcare Fund (Master), LPCIK 0001949026 | 10% Owner |
| Decheng Capital Global Healthcare GP, LLCCIK 0001949027 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 14, 2025 | Common Stock | CConversionAcquired | +2,333,887 | – | – | 2,333,887 | Indirect | |
| Feb 14, 2025 | Common Stock | CConversionAcquired | +333,412 | – | – | 333,412 | Indirect | |
| Feb 14, 2025 | Common Stock | PPurchaseAcquired | +625,000 | $16.00 | +$10,000,000 | 2,958,887 | Indirect | |
| Feb 14, 2025 | Common Stock | PPurchaseAcquired | +625,000 | $16.00 | +$10,000,000 | 958,412 | Indirect |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 14, 2025 | Common Stock | CConversionDisposed | −2,333,887 | $0.00 | $0 | 0 | Indirect | |
| Feb 14, 2025 | Common Stock | CConversionDisposed | −333,412 | $0.00 | $0 | 0 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.